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Background: Compounds based on trans-1,2-diphenylethene are the subject of intense interest both for their
optical properties and as potential leads for drug discovery, as a consequence of their anticancer, anti-inflammatory
and antioxidant properties. Perhaps the best known of these is trans-3,5,4′-trihydroxystilbene (resveratrol), that has
been identified as a promising lead in the search for anti-ageing therapeutics.
Results: We report here a new, convenient, one-pot stereo-selective synthesis of resveratrol and other trans-stilbene
derivatives. A wide range of known and novel “Resveralogues” were synthesised by using this simple protocol,
including examples with electron donating and electron withdrawing substituents, in uniformly high yield. The
structures of all compounds were confirmed by standard methods including 1H and 13C NMR, IR and High Resolution
Mass spectroscopy.
Conclusions: We have established a simple and convenient protocol for resveralogue synthesis. It is readily scalable,
and sufficiently robust and simple for ready use in automated synthesis or for library development of resveralogues.
This supersedes previously reported synthetic methods that required inert conditions, extensive purification and/or
costly reagents.
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trans-1,2-Diphenylethene is the basic structural unit in
a wide variety of naturally-occurring molecules. These,
and synthetic analogues, have been deployed in pho-
tochemical dyes and fluorescent whitening agents [1],
polymeric materials [2, 3], and are the subject of intense
interest as potential leads for drug discovery as a conse-
quence of their anticancer [4, 5] anti-inflammatory [6]
and antioxidant properties [7]. Perhaps the best known
of these is trans-3,5,4′-trihydroxystilbene (resveratrol),
which has shown potential clinical value as a dietary
restriction mimetic. Such mimetics are thought to slow
the rate of deleterious processes associated with ageing
and thus have the potential to prevent, or even reme-
diate, multiple age-associated degenerative pathologies,
including cognitive impairment, arthritis, cardiovascular
disease and immune dysfunction [8, 9]. trans-Stilbenes
thus represent attractive scaffolds for future compound* Correspondence: e.ostler@brighton.ac.uk
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reproduction in any medium, provided the odevelopment. However, resveratrol itself has been shown
to have a range of activities, some of which may actually
be detrimental to health. Equally, resveratrol is very limi-
ted in its bioavailability and, taken together, these issues
leave uncertainties about its likely in vivo modes of ac-
tion and consequent clinical utility. There is therefore a
need for simple and versatile syntheses of a wide variety
of structural analogues of resveratrol, or resveralogues,
in order to facilitate detailed investigation of stilbenoid
structure-activity relationships, and to allow develop-
ment of potential therapeutic compounds with improved
bioavailability.
trans-Stilbene derivatives are generally synthesised uti-
lising Wittig or Horner- Wadsworth- Emmons (HWE)
reactions and through catalytic methods such as Heck,
Suzuki and Negishi coupling reactions or through the
use of organozinc reagents [10]. Many of the examples
in the literature suffer from incomplete conversion and
low yields, or poor stereoselectivity. Of the existing
methods, three have been previously modified to one-
pot syntheses. These utilised the oxidative Wittig-Heckn Open Access article distributed under the terms of the Creative Commons
org/licenses/by/4.0), which permits unrestricted use, distribution, and
riginal work is properly credited.
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of aryl bromide [13] and organozinc reagents [10]. Al-
though some of these protocols provide good yields, they
tend to require costly organometallic catalysts, inert re-
action conditions, large excesses of reagents [13], long
reaction times (>40 h in some instances) and/or complex
solvent mixtures. We present here the first example of
a robust, one-pot, readily scalable synthesis of diverse
trans-stilbene derivatives and resveralogues.
Results and discussion
We have developed a simple and convenient one-pot
method using sequential Michaelis-Arbuzov rearrange-
ment and HWE chemistry. The overall reaction scheme
is shown below (Scheme 1).
Our synthetic protocol reduces both reaction time and
reagent usage, by removing the need for isolation and
purification both at the intermediate step and in the final
product. A wide variety of analogues can conveniently
be prepared from existing readily available benzyl bro-
mides and benzaldehyde derivatives. We here describe
the preparations of a range (1–16 below) of examples of
resveralogues including several novel compounds (2, 4,
6, 8, 15 and 16), in good yield and purity, with minimal
waste and manipulative steps.
Our method is facile, versatile and cost effective. We
have applied this protocol to the synthesis of a range of
differently substituted derivatives and in each case the re-
quired trans-stilbene was produced in good yield either
without purification or through simple recrystallisation.
The compounds were characterised by 1H NMR, 13C
NMR, IR, high resolution mass spectroscopy and melting
point, and where possible confirmed by comparison to
literature values. The characteristic pattern of trans-coup-
ling constant (J) value (more than 15 MHz) was observed
in the 1H NMR spectra of all compounds synthesised, and
indicated >95 % trans selectivity, in that signals from the
alternate isomer were not observed.
Experimental
We selected the Michaelis-Arbuzov rearrangement as
the most versatile method available for preparation of
phosphonate esters [14, 15]. In this step, we reacted the
starting substituted benzyl bromides with a single molar
equivalent of triethylphosphite in the absence of solvent











Scheme 1 One-pot synthesis of resveralogueslarge excesses of triethylphosphite utilised in earlier
reports and also avoids potential by-product formed as
a consequence of the reaction of ethyl bromide with the
excess triethylphosphite. It is usual, at this stage, to iso-
late and then purify the diethylphosphonate intermediate
via column chromatography or distillation [16]. In our
protocol, however, we continue directly to the HWE
reaction, giving the desired stilbenes in high yield and
purity. In most cases the conversion to trans-stilbene is
complete after 12 h of heating to reflux, and the product
can be crystallised directly from the reaction mixture by
simple addition of ice and a small quantity of methanol.
Where necessary, further purification can be achieved by
recrystallisation from ethanol. The choice of base for the
HWE reaction is important to the success of this one
pot synthesis. Our initial efforts focused on the reaction
of 2- and 4- substituted phosphonates to give the relevant
stilbenes and these proceed readily to completion with the
use of 1.2 equivalents of potassium t-butoxide as base.
However, when deactivating meta and/or electron dona-
ting substituents are present potassium t-butoxide is un-
successful and a stronger base must be used. We found
that 1.1 equivalents of sodium methoxide was sufficient to
ensure the reaction proceeded successfully when such
groups were present, although in some cases the yield was
a little reduced.
Conclusions
Our one-pot protocol is very efficient and stereoselective
for the synthesis of a wide range of resveralogues. The
utility and applicability of this method is enhanced by its
simple work up procedure, rendering it also suitable for
use in automated synthesis.
Methods
General
The starting materials and solvent, reagents were ob-
tained commercially and used directly without purifica-
tion. The NMR spectra of compounds were recorded on
Brüker FT-NMR 400Hz spectrometer in CDCl3 using
tetramethylsilane (TMS) as an internal standard. The δ
values represent chemical shifts reported in parts per
million (ppm) and coupling constant (J) values are in
Hz. Assignments correspond to R and R’ as per Table 1,
numbering each ring from the carbon closest to the
central double bond. 13C NMR spectra were definitively
assigned with reference to HSQC correlation spectra
(not presented). ESI-MS and ESI-HRMS were recorded
on a Brüker MicroTOF instrument. Melting points
were recorded on an Electrothermal melting point ap-
paratus and are uncorrected. Flash chromatography was
conducted by using Silica size (100–200 mesh). Thin
layer chromatography was performed on TLC Silica Gel
60 F254 (Merck).
Table 1 Preparation of resveralogues
R’† R† Yield (%)
1 2-CN 3,5-dimethoxy 71
2 3-Cl 4-N(Me)2 79
3 2-NO2 3,5-dimethoxy 80
4 2-F 3,5-dimethoxy 74
5 2-NO2 4-OMe 79
6 3-Cl 3,5-dimethoxy 68
7 3-CF3 4-N(Me)2 74
8 3,5-dimethyl 3,5-dimethoxy 81
9 2,4-difluoro 3,5-dimethoxy 74
10 4-Me 3,5-dimethoxy 84
11 4-CN 3,5-dimethoxy 80
12 4-OMe 3,5-dimethoxy 60
13 4-COOMe 3,5-dimethoxy 59
14 4-NO2 3,5-dimethoxy 90
15 2,6-difluoro 3,5-dimethoxy 78
16 2,6-dichloro 3,5-dimethoxy 79
†R’ being the substituent(s) of the benzyl bromide starting material and R,
the aldehyde
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trans-stilbenes
To a two-necked oven dried round-bottomed flask, the
required benzyl bromide (500 mg, 1 equivalent) and
triethylphosphite (1 equivalent) were added with N2 pur-
ging. This reaction mixture was heated at 150 °C for
4-5 h. The reaction was monitored by thin layer chroma-
tography (eluent 10:90::ethyl acetate: petroleum ether).
After completion, the reaction mixture was cooled to
room temperature and then diluted tenfold with N,N-
dimethylformamide. Base (for procedure A, KOtBu (1.1
equivalents) and for procedure B, NaOMe (1.2 equivalents))
was added and stirred at room temperature for 10 min.
Aldehyde (0.8 equivalents) was then added to the reaction
mixture which was then stirred at room temperature for a
further hour. After this time it was heated to reflux for
12 h. The reaction was cooled to room temperature and
quenched by adding ice and a small amount of methanol.
The resulting precipitate was then filtered and dried to
give the crude stilbene as title product. The crude product
was recrystallised from ethanol or ethyl acetate to give fine
and pure crystals.
(E)-2-(3,5-dimethoxystyryl)benzonitrile (1)
Procedure A gave 478 mg white solid (71 %), m.p. = 72–
73 °C, Rf (10:90::ethyl acetate:petroleum ether) = 0.27, IR ν
(cm-1) = 3068, 2948, 2838, 2219, 1588, 1425, 1352, 1152,
1056, 958, 755, 1H NMR (400 MHz, CDCl3) δ (ppm) =
3.84 (6H, s, -OMe), 6.45 (1H, t, J2Hz, H4), 6.72 (2H, d,J2Hz, H2, H6), 7.19 (1H, d, J16Hz, -C = C-H), 7.33 (1H,
td, J7.6,1.1Hz, H4′), 7.41 (1H, d, J16Hz, -C = C-H), 7.57
(1H, td, J7.6, 1Hz, H5′), 7.65 (1H, dd, J8.0, 1Hz, H6′), 7.78
(1H, d, J8.0Hz, H3′). 13C NMR (100 MHz, CDCl3) δ
(ppm) = 55.4 (OMe), 101.2 (C4), 105.2 (C2, C6), 111.3
(C2′), 117.4 (CN), 124.6 (C = C), 125.4 (C3′), 127.6 (C4′),
132.7 (C5′), 133.2 (C6′), 133.5 (C = C), 138.2 (C1′), 140.4
(C1), 161.1 (C3, C5). HRMS m/z calculated 288.09950
[(M +Na)]+ and 533.20978 [2 M+Na]+, found 288.09945
and 553.20737.
(E)-4-(3-chlorostyryl)-N,N-dimethylaniline (2)
Procedure B gave 495 mg white solid (79 %). m.p. = 138–
139 °C. Rf (10:90::ethyl acetate:petroleum ether) = 0.56,
IR ν (cm-1) = 3031, 2893, 1608, 1582, 1065, 965, 808,
730, 1H NMR (400 MHz, CDCl3) δ (ppm) = 2.98 (6H,
s, -N(CH3)2), 6.71 (distorted d, J8.8 Hz, H3, H5), 6.83
(1H, d, J16.4Hz, -C =C-H), 7.02 (1H, d, J16.4Hz, -C =C-H),
7.15 (1H, ddd, J8.0, 2.0,1.2, H6′), 7.24 (1H, t, J8Hz, H5′),
7.32 (1H, distorted d, J7.6Hz, H4′), 7.40 (2H, distorted
d, J8.8Hz, H2, H6), 7.45 (1H, t, J3.5Hz, H2′), 13C NMR
(100 MHz, CDCl3) δ (ppm) = 40.4 (N(CH3)2), 112.4
(C3,C5), 122.8 (C = C), 124.2 (C4′), 125.4 (C1), 125.8
(C2′), 126.5 (C6′), 127.8 (C2, C6), 129.7 (C5′), 130.3 (C =C),
134.5 (C1′), 140.2 (C3′), 150.4 (C4). HRMS (ESI) calcu-
lated m/z 258.10440 [(M +H)]+, found 258.09288.
(E)-1,3-dimethoxy-5-(2-nitrostyryl)benzene (3)
Procedure A gave 528 mg yellow solid (80 %), m.p. =
72–73 °C, Rf (10:90::ethyl acetate:petroleum ether) =
0.27, IR ν (cm-1) = 3004, 2940, 2838, 1599, 1516, 1342,
1205, 1154, 1054, 951, 819, 744, 670, 1H NMR
(400 MHz, CDCl3) δ (ppm) = 3.83 (6H, s, -OMe), 6.44
(1H, t, J2.4Hz, H4), 6.68 (2H, d, J2.4Hz, H2, H6), 7.00
(1H, d, J16.4Hz, H-C = C-), 7.40 (1H, td, J8.4,1.3Hz,
H4′), 7.59 (1H, d, J16Hz, H-C = C-), 7.59 (1H, t, J7.4Hz,
H5′), 7.74 (d, J7.6Hz, H6′), 7.96 (1H, dd, J8.1,1.1Hz,
H3′), 13C NMR (100 MHz, CDCl3) δ (ppm) = 55.4
(OMe), 100.9 (C4), 105.2 (C2, C6), 124.0 (C = C), 124.8
(C3′), 128.0 (C4′), 128.2 (C6′), 132.9 (C5′), 133.1 (C = C),
133.9 (C1′), 138.5 (C1), 148.1 (C2′), 161.1 (C3, C5).
HRMS calculated m/z 308.08933 [(M + Na)]+, found
308.10436.
(E)-1-(2-fluorostyryl)-3,5-dimethoxybenzene (4)
Procedure B gave 505 mg shiny white crystals (74 %),
m.p. = 62 °C, Rf (10:90::ethyl acetate:petroleum ether) =
0.64, IR ν (cm-1) = 3001, 2997, 2954, 1590, 1488, 1357,
1152, 1053, 966, 825, 677, 1H NMR (400 MHz, CDCl3) δ
(ppm) = 3.83 (6H, s, -OMe), 6.41 (1H, t, J2.2 Hz, H4),
6.69 (d, J2.2Hz, H2, H6), 7.15-7.08 (3H, m (includes d,
J16.4Hz), H3′, H6′, -C = C-H), 7.26-7.22 (2H, m (includes
d, J16.4Hz), H5′, -C = C-H), 7.59 (1H, td, J = 7.7,1.6Hz,
H4′), 13C NMR (100 MHz, CDCl3) δ (ppm) = 55.4
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21.92Hz), 121.5 (C = C, JC-F 3.1Hz), 124.2 (C6′, JC-F
3.1Hz), 125.1 (C1′, JC-F 11.7Hz), 127.2 (C4′, JC-F 3.5Hz),
128.9 (C5′, JC-F 8.5Hz), 131.0 (C = C, JC-F 4.68Hz), 139.3
(C1), 161.0 (C3, C5), 160.5 (C2′, JC-F 247.9Hz). HRMS cal-
culated m/z 281.09483 [(M +Na)]+, found 281.07161.
(E)-1-(4-methoxystyryl)-2-nitrobenzene (5)
Procedure A gave 466 mg yellow solid (79 %), m.p. =
66–69 °C (literature m.p. = 69.9 °C, [17]), Rf (10:90::ethyl
acetate:petroleum ether) = 0.64, IR ν (cm-1) = 3081, 2977,
2938, 1600, 1505, 1422, 1337, 1250, 1054, 968, 822, 768,
1H NMR (400 MHz, CDCl3) δ (ppm) = 3.82 (3H, s,
OMe), 6.90 (2H, dd, J8.8, 2Hz, H2, H6), 7.04 (1H, d,
J16Hz, -C = C-H), 7.34 (td, J8.3,1.3Hz, H4′), 7.34–7.48
(3H, m (includes d, J16Hz), H3, H5, -C = C-H), 7.55 (1H,
td, J7.4, 0.9Hz, H5′), 7.72 (1H, dd, J7.8, 0.9Hz, H6′), 7.91
(1H, dd, J8.2, 1.2Hz, H3′), 13C NMR (100 MHz, CDCl3)
δ (ppm) = 55.4 (OMe), 114.3 (C2, C6), 121.1 (C = C),
124.8 (C3′), 127.5 (C4′) 127.9 (C6′), 128.5 (C3, C5),
129.3 (C1′), 133.0 (C1), 133.3 (C5′), 133.5 (C = C), 147.9
(C2′), 160.1 (C4). HRMS calculated m/z 278.07876
[(M +Na)]+, found 278.07100.
(E)-1-(3-chlorostyryl)-3,5-dimethoxybenzene (6)
Procedure B gave, after purification, 454 mg colourless
liquid (68 %), b.p. >300 °C, Rf (10:90::ethyl acetate:
petroleum ether) = 0.47, IR ν (cm-1) = 3030, 2995, 2898,
1603, 1542, 1357, 1205, 1053, 968, 825, 677, 1H NMR
(400 MHz, CDCl3) δ (ppm) = 3.83 (6H, s, OMe), 6.41
(1H, t, J2.2Hz, H4), 6.66 (2H, d, J2.2Hz, H2, H6), 6.98
(1H, distorted d, J16.2Hz, -C = C-H), 7.03 (1H, distorted
d, J16.2Hz, -C = C-H), 7.22 (1H, dt, J8.4,1.2Hz H6′), 7.26
(1H, dd, J8.8, 7.6Hz, H5′), 7.35 (dt, J7.5, 1.2Hz, H4′),
7.49 (1H, t, J1.6Hz, H2′), 13C NMR (100 MHz, CDCl3) δ
(ppm) = 55.4 (OMe), 100.4 (C4), 104.8 (C2, C6), 124.8
(C4′), 126.4 (C2′), 127.6 (C6′), 127.7 (C = C), 129.9
(C5′), 130.2 (C = C), 134.7 (C1′), 138.84 (C3′), 139.08
(C1), 161.06 (C3, C5). HRMS calculated m/z 297.06528
[(M +Na)]+ and 571.14134 [(2 M+Na)]+, found 297.06374
and 571.13963.
(E)-N,N-dimethyl-4-(3-(trifluoromethyl)styryl)aniline (7)
Procedure B gave 450 mg light green crystals (74 %), m.p. =
146 °C, Rf (10:90::ethyl acetate:petroleum ether) = 0.56,
IR ν (cm-1) = 3026, 2810, 1601, 1521, 1327, 1115, 1071,
965, 1H NMR (400 MHz, CDCl3) δ (ppm) = 2.99 (6H,
s, -N(CH3)2), 6.72 (2H, dd, J7.2, 2.0Hz, H2, H6), 6.91 (1H,
d, J16.0Hz, -C = C-H), 7.10 (1H, d, J16.0Hz, -C = C-H),
7.40–7.44 (4H, m, H4′, H6′, H3, H5), 7.62 (1H, distorted
t, H5′), 7.70 (1H, s, H2′), 13C NMR (100 MHz, CDCl3)
δ (ppm) = 40.4 (N(CH3)2), 112.4 (C2, C6), 122.5 (C2′, JC-F
3Hz), 122.7 (C = C), 123.0 (C6′, JC-F 3Hz), 125.0 (C3′),
125.6 (C1′), 127.84 (C3, C5), 128.94 (C5′), 128.99 (C4′),130.7 (C = C), 131.0 (CF3, JC-F 32Hz), 139.1 (C1), 150.5
(C4). HRMS calculated m/z 292.13076 [(M +H)]+, found
292.13062.
(E)-1-(3,5-dimethoxystyryl)-3,5-dimethylbenzene (8)
Procedure B gave, after purification, 545 mg white solid
(81 %), m.p. = 66–68 °C, Rf (10:90::ethyl acetate:petro-
leum ether) = 0.47, IR ν (cm-1) = 3256, 3009, 2923, 1598,
1463, 1326, 1164, 1071, 962, 839, 690, 1H NMR
(400 MHz, d6-DMSO) δ (ppm) = 2.29 (6H, s, CH3), 3.78
(6H, s, OMe), 6.40 (1H, t, J2.4Hz, H4), 6.75 (2H, d,
J2.4Hz, H2, H6), 6.91 (broad s, H4′), 7.11 (1H, d,
J16.4Hz, C = C-H), 7.18 (1H, d, J16.4Hz, C = C-H), 7.25
(broad s, H2′, H6′), 13C NMR (100 MHz, d6-DMSO) δ
(ppm) = 20.9 (Me), 55.1 (OMe), 99.8 (C4), 104.3 (C2,
C6), 124.3 (C2′, C6′), 128.0 (C = C), 129.0 (C = C), 129.2
(C4′), 136.7 (C1′), 137.5 (C3′, C5′), 139.1 (C1), 160.6
(C3, C5). HRMS calculated m/z 291.13555 [(M +Na)]+,
found 291.13523.
(E)-1-(3,5-dimethoxystyryl)-2,4-difluorobenzene (9)
Procedure B gave 494 mg white crystals (74 %), m.p. =
72–74 °C (literature m.p. = 78 °C, [18]), Rf (10:90::ethyl
acetate:petroleum ether) = 0.64, IR ν (cm-1) = 3065, 2948,
2841, 1589, 1460, 1281, 1152, 1054, 965, 813, 676, 1H
NMR (400 MHz, CDCl3) δ (ppm) = 3.83 (6H, s, OMe),
6.42 (1H, t, J2.4Hz, H4), 6.67 (2H, d, J2.4Hz, H2, H6),
6.80–6.91 (2H, m, H5′ and H6′), 7.02 (1H, d, J16.4Hz, -C =
C-H), 7.16 (1H, d, J16.4Hz, -C =C-H), 7.55 (1H, distorted
dd, JHF15.8, 8.4Hz, H3′),
13C NMR (100 MHz, CDCl3) δ
(ppm) = 55.4 (OMe), 100.4 (C4), 104.2 (C6′, JC-F25.6Hz),
104.7 (C2, C6), 111.7 (C5′, JC-F21.31 and 3.63Hz), 120.5
(C = C), 121.5 (C1′, JC-F8.2 Hz), 128.0 (C3′, JC-F5.17Hz),
130.7 (C = C, JC-F2.3Hz), 139.1 (C1), 160.4 (C4′, JC-F250.6,
11.6 Hz), 161.0 (C3, C5), 162.2 (C2′, JC-F248.3, 11.8Hz).
HRMS calculated m/z 299.08541 [(M+Na)]+ and 575.18159
[(2 M +Na)]+, found 299.10167 and 575.20262.
(E)-1,3-dimethoxy-5-(4-methylstyryl)benzene (10)
Procedure A gave 577 mg white crystals (84 %), m.p. =
56–57 °C (literature m.p. = 50–52 °C, [19]), Rf (10:90::ethyl
acetate:petroleum ether) = 0.54, IR ν (cm-1) = 3029, 2961,
2937, 1585, 1450, 1290, 1148, 955, 831, 754, 1H NMR
(400 MHz, CDCl3) δ (ppm) = 2.36 (3H, s, Me), 3.83 (6H, s,
OMe), 6.39 (1H, t, J2.2Hz, H4), 6.66 (2H, d, J2.2Hz, H2,
H6), 7.02 (1H, d, J16.2Hz, C = C-H), 7.06 (1H, d,
J16.2Hz, C = C-H), 7.16 (2H, d, J7.9Hz, H2′, H6′), 7.40
(2H, d, J8.0Hz, H3′, H5′), 13C NMR (100 MHz, CDCl3)
δ (ppm) = 21.2 (Me), 55.4 (OMe), 99.9 (C4), 104.5 (C2,
C6), 126.5 (C3′, C5′), 127.7 (C = C), 129.9 (C = C), 129.4
(C2′, C6′), 134.4 (C1′), 137.7 (C4′), 139.6 (C1), 161.01
(C3, C5). HRMS calculated m/z 277.11990 [(M + Na)]+,
found 277.12461.
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Procedure A gave 541 mg white solid (80 %), m.p. = 105–
107 °C (literature m.p. = 106–107 °C, [20]), Rf (10:90::ethyl
acetate:petroleum ether) = 0.54, IR ν (cm-1) = 2959, 2937,
2841, 2220, 1587, 1340, 1208, 1169, 1066, 948, 833, 679,
1H NMR (400 MHz, CDCl3) δ (ppm) = 3.84 (6H, s, OMe),
6.45 (1H, t, J2.2Hz, H4), 6.68 (2H, d, J2.2Hz, H2, H6), 7.05
(1H, d, J16.2Hz, -C = C-H), 7.13 (1H, d, J16.2Hz, -C =
C-H), 7.59 (2H, d, J8.3Hz, H2′, H6′), 7.64 (2H, d, J8.3Hz,
H3′, H5′), 13C NMR (100 MHz, CDCl3) δ (ppm) = 55.4
(OMe), 100.9 (C4), 105.1 (C2, C6), 110.7 (C4′), 119.0
(CN), 126.9 (C2′, C6′), 127.2 (C = C), 132.4 (C = C), 132.6
(C3′, C5′), 138.3 (C1′), 141.7 (C1), 161.1 (C3, C5). HRMS
calculated m/z 288.09950 [(M +Na)]+, found 288.12135.
(E)-1,3-dimethoxy-5-(4-methoxystyryl)benzene (12)
Procedure B gave, after purification, 403 mg white solid
(60 %), m.p. = 59–61 °C (literature m.p. = 55–58 °C,
[21]), Rf (10:90::ethyl acetate:petroleum ether) = 0.48, IR
ν (cm-1) = 2960, 2912, 2837, 1605, 1517, 1442, 1239, 965,
824, 1H NMR (400 MHz, CDCl3) δ (ppm) = 3.83 (9H, s,
OMe), 6.38 (1H, t, J2.0Hz, H4), 6.65 (2H, d, J2.0Hz, H2,
H6), 6.89 (2H, d, J8.8Hz, H2′, H6′), 6.90 (1H, d,
J16.2Hz, -C = C-H), 7.04 (1H, d, J16.2Hz, -C = C-H), 7.44
(d, J8.8Hz, H3′, H5′), 13C NMR (100 MHz, CDCl3)
δ(ppm) = 55.3 (OMe), 55.4 (2xOMe), 99.7 (C4), 104.4 (C2,
C6), 114.2 (C2′, C6′), 126.6 (C = C), 127.8 (C3′,C5′),
128.8 (C = C), 130.0 (C1′), 139.7 (C1), 159.4 (C4′), 161.0
(C3, C5). HRMS calculated m/z 293.11482 [(M +Na)]+,
found 293.09290.
Methyl (E)- 4-(3,5-dimethoxystyryl)benzoate (13)
Procedure A gave 384 mg white solid (59 %), m.p. = 121–
122 °C (literature m.p. = 117–121 °C, [22]), Rf (10:90::ethyl
acetate:petroleum ether) = 0.51, IR ν (cm-1) = 3080, 2999,
2945, 1708, 1587, 1433, 1273, 1152, 966, 697, 1H NMR
(400 MHz, CDCl3) δ (ppm) = 3.83 (6H, s, OMe), 3.92 (3H,
s, COOMe), 6.43 (1H, t, J2.2Hz, H4), 6.69 (2H, d, J2.2Hz,
H2, H6), 7.08 (1H, d, J16.4Hz, -C = C-H), 7.14 (1H, d,
J16.4Hz, -C = C-H), 7.55 (2H, d, J8.3Hz, H2′, H6′), 8.02
(d, J8.2Hz, H3′, H5′), 13C NMR (100 MHz, CDCl3)
δ (ppm) = 52.1 (COOMe), 55.4 (OMe), 100.6 (C4), 104.9
(C2, C6), 126.4 (C2′, C6′), 128.1 (C = C), 129.0 (C1′),
130.03 (C3′,C5′), 131.2 (C = C), 138.8 (C1), 141.65 (C4′),
161.1 (C3, C5), 166.8 (COOMe). HRMS calculated m/z
321.10973 [(M +Na)]+ and 619.23024 [(2 M +Na)]+,
found 321.10598 and 619.22537.
(E)-1,3-dimethoxy-5-(4-nitrostyryl)benzene (14)
Procedure A gave 594 mg yellow solid (90 %), m.p. = 137–
138 °C (literature m.p. = 135–137 °C, [23]), Rf (10:90::ethyl
acetate:petroleum ether) = 0.48, IR ν (cm-1) = 3051, 2839,
1636, 1592, 1503, 1329, 1295,1205, 1106, 948, 824, 1H
NMR (400 MHz, CDCl3) δ (ppm) = 3.86 (6H, s, OMe),6.47 (1H, t, J2.4Hz, H4), 6.71 (2H, d, J2.4Hz, H2, H6), 7.11
(1H, d, J18.0Hz, -C =C-H), 7.20 (1H, d, J18.0Hz, -C =C-H),
7.63 (2H, d, J9.7Hz, H2′, H6′), 8.22 (2H, d, J9.7Hz,
H3′, H5′), 13C NMR(100 MHz, CDCl3) δ(ppm) = 55.4
(OMe), 101.0 (C4), 105.12 (C2, C6), 124.1 (C3′, C5′),
126.8 (C = C), 126.9 (C2′,C6′), 133.3 (C = C), 138.1
(C1′), 143.7 (C1), 146.8 (C4′), 161.1 (C3, C5). HRMS
calculated m/z 308.08933 [(M + Na)]+, found 308.08817.
(E)-2-(3,5-dimethoxystyryl)-1,3-difluorobenzene (15)
Procedure A gave 520 mg shiny white crystals (78 %), m.p.
85–86 °C, Rf (10:90::ethyl acetate:petroleum ether) = 0.64, IR
ν (cm-1) = 3009, 2973, 2844, 1589, 1463, 1306, 1200, 1152,
979, 788, 682, 1H NMR (400 MHz, CDCl3) δ (ppm) = 3.83
(6H, s, OMe), 6.43 (1H, t, J2.2Hz, H4), 6.69 (2H, d, J2.2Hz,
H2, H6), 6.92 (2H, t, J8.4Hz, H3′, H5′), 7.10 (d, J16.8Hz,
-C =C-H) 7.15 (1H, tt, J8.4, 8.4Hz, H4′), 7.37 (1H, d,
J16.4Hz, -C =C-H), 13C NMR (100 MHz, CDCl3) δ (ppm) =
55.4 (OMe), 100.6 (C4), 104.7 (C2, C6), 111.7 (C3′, C5′,
JC-F6.47), 114.7 (C1′, JC-F15.1Hz), 115.7 (C = C), 128.0
(C4′, JC-F10.7Hz), 135.1 (C = C, JC-F8.35 Hz), 139.6 (C1),
160.9 (C2′, C6′, JC-F250, 7.7 Hz), 161.0 (C3, C5). HRMS
calculated m/z 299.08541 [(M +Na)]+, found 299.10582.
(E)-1,3-dichloro-2-(3,5-dimethoxystyryl)benzene (16)
Procedure B gave 508 mg, white solid (79 %), m.p. 66–67 °C,
Rf (10:90::ethyl acetate:petroleum ether) = 0.64, IR ν
(cm-1) = 2959, 2897, 2833, 1598, 1424, 1348, 1206, 1152,
1054, 965, 819, 763, 676, 1H NMR (400 MHz, d6-DMSO)
δ (ppm) = 3.78 (6H, s, OMe), 6.48 (1H, t, J2.0Hz, H4), 6.78
(2H, d, J2.0Hz, H2, H6), 6.99 (1H, d, J16.4Hz, -C = C-H),
7.15 (1H, d, J16.4Hz, -C = C-H), 7.32 (1H, t, J8.0Hz, H4′),
7.52 (2H, d, J8.0Hz, H3′, H5′), 13C NMR (100 MHz,
d6-DMSO) δ (ppm) = 55.3 (OMe), 100.9 (C4), 104.7 (C2,
C6), 122.7 (C = C), 128.8 (C3′, C5′), 129.3 (C4′), 133.6
(C2′, C6′), 134.1 (C1’), 136.8 (C = C), 138.1 (C1), 160.7
(C3, C5). HRMS calculated m/z 331.02631 [(M +Na)]+
and 641.06044 [(2 M +Na)]+, found m/z 331.04468 and
641.09081.
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